# MCRB (Seres Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Seres Therapeutics, Inc. reported $2.12M in revenue and a net loss of $46.95M for the trailing twelve months ended September 30, 2026 (up 68.9% year over year), with a -3656.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/MCRB
- Markdown: https://convexityos.com/fundamentals/MCRB.md
- SEC CIK: 0001609809
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:04 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001609809&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $2.12M | +68.9% YoY |
| Operating Income | TTM | -$77.71M | -3656.9% margin |
| Net Income | TTM | -$46.95M | -2209.6% net margin |
| Diluted EPS | TTM | -$4.70 | Split-adjusted |
| Free Cash Flow | TTM | -$63.97M | -3010.4% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $17.53M | Total debt: $35.77M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $789K | $0 | $0 | $7.13M | $144.9M | $33.22M | $34.51M | $28.27M | $32.10M | $21.77M |
| Research & Development | $49.06M | $64.60M | $117.6M | $109.7M | $141.9M | $90.57M | $80.14M | $95.95M | $89.45M | $81.99M |
| Total Operating Expenses | $94.76M | $121.3M | $195.1M | $179.9M | $209.4M | $121.3M | $106.4M | $128.6M | $123.5M | $114.6M |
| **Operating Income** | -$93.97M | -$121.3M | -$195.1M | -$179.9M | -$64.49M | -$88.13M | -$71.88M | -$100.3M | -$91.39M | -$92.84M |
| **EBITDA** | -$89.84M | -$115.8M | -$188.9M | -$173.3M | -$58.55M | -$81.55M | -$64.27M | -$92.42M | -$84.14M | -$88.63M |
| Interest Income | $2.23M | $3.97M | $7.30M | $3.06M | $2.87M | $946K | $1.03M | $1.17M | $1.59M | $2.23M |
| Interest Expense | $0 | $0 | $2.47M | $6.02M | $2.91M | $2.92M | $502K | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | $5.70M | $136K | -$113.7M | -$250.2M | -$65.58M | -$89.13M | -$70.28M | -$98.94M | -$89.38M | -$91.58M |
| Basic EPS | $0.64 | $0.00 | -$17.77 | -$2.31 | -$0.72 | -$1.12 | -$1.24 | -$2.43 | -$2.21 | -$2.30 |
| **Diluted EPS** | $0.64 | $0.00 | -$17.77 | -$2.31 | -$0.72 | -$1.12 | -$1.24 | -$2.43 | -$2.21 | -$2.30 |
| Basic Shares Outstanding | 8.9M | 7.8M | 6.4M | 108.1M | 91.7M | 79.8M | 56.6M | 40.7M | 40.4M | 39.8M |
| Diluted Shares Outstanding | 8.9M | 7.8M | 6.4M | 108.1M | 91.7M | 79.8M | 56.6M | 40.7M | 40.4M | 39.8M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $593K | $736K | $358K | $438K | $351K | $0 | $0 | $0 |
| Research & Development | $5.59M | $9.14M | $13.20M | $11.68M | $12.62M | $12.94M | $11.82M | $12.84M |
| Total Operating Expenses | $16.75M | $22.01M | $21.27M | $19.82M | $22.83M | $24.88M | $27.24M | $28.84M |
| **Operating Income** | -$16.15M | -$21.27M | -$20.91M | -$19.38M | -$22.48M | -$24.88M | -$27.24M | -$28.84M |
| **EBITDA** | -$15.67M | -$20.60M | -$20.13M | -$18.42M | -$21.43M | -$23.82M | -$26.16M | -$27.75M |
| Interest Income | $146K | $181K | $325K | $445K | $618K | $546K | $618K | $437K |
| Interest Expense | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$16.29M | $4.58M | -$19.91M | -$15.34M | $8.20M | -$19.86M | $32.68M | -$15.64M |
| Basic EPS | -$1.63 | $0.47 | -$2.08 | -- | $0.94 | -$2.27 | $3.76 | -- |
| **Diluted EPS** | -$1.63 | $0.47 | -$2.08 | -- | $0.94 | -$2.27 | $3.75 | -- |
| Basic Shares Outstanding | 10.0M | 9.7M | 9.6M | -- | 8.8M | 8.7M | 8.7M | -- |
| Diluted Shares Outstanding | 10.0M | 9.7M | 9.6M | -- | 8.8M | 8.7M | 8.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $45.77M | $30.79M | $128.0M | $163.0M | $180.0M | $116.0M | $65.13M | $85.82M | $36.09M | $54.54M |
| Short-Term Investments | -- | -- | $0 | $18.31M | $110.7M | $137.6M | $29.69M | $0 | $113.9M | $138.7M |
| **Cash & Short-Term Investments** | $45.77M | $30.79M | $128.0M | $181.3M | $290.7M | $253.6M | $94.82M | $85.82M | $150.0M | $230.0M |
| Accounts Receivable, Net | $157K | $0 | -- | -- | -- | $9.39M | $1.78M | -- | -- | -- |
| Inventory | -- | -- | $29.65M | $0 | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $49.38M | $38.67M | $175.4M | $194.8M | $303.6M | $268.8M | $100.2M | $92.67M | $155.1M | $198.4M |
| Property, Plant & Equipment, Net | $7.63M | $11.53M | $17.61M | $22.98M | $17.94M | $13.90M | $19.50M | $26.29M | $32.93M | $36.12M |
| Long-Term Investments | -- | -- | -- | $0 | $495K | $49.83M | -- | -- | -- | $36.75M |
| Other Non-Current Assets | $31K | $31K | $2.19M | $10.46M | $5.19M | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $88.82M | $101.1M | $183.2M | $154.0M | $51.23M | $74.16M | $32.25M | $27.81M | $34.44M | $74.28M |
| **Total Assets** | $138.2M | $139.8M | $358.6M | $348.8M | $354.9M | $342.9M | $132.4M | $120.5M | $189.5M | $272.6M |
| Accounts Payable | $1.68M | $4.08M | $3.64M | $17.44M | $13.73M | $4.02M | $4.86M | $6.42M | $7.03M | $7.59M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | $4.83M | $20.42M | $12.08M | -- |
| **Total Current Liabilities** | $19.32M | $41.22M | $98.66M | $85.60M | $82.26M | $46.41M | $45.99M | $42.04M | $31.62M | $30.46M |
| Long-Term Debt | -- | -- | $110.0M | $50.00M | $24.05M | $25.00M | $25.00M | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | $4.83M | $116.8M | $84.85M | -- |
| Other Non-Current Liabilities | $2.08M | $1.84M | $1.63M | $1.44M | $11.49M | $1.00M | $502K | $644K | $1.13M | -- |
| **Total Non-Current Liabilities** | $74.65M | $84.80M | $304.8M | $252.4M | $141.1M | $121.8M | $134.8M | $126.5M | $97.20M | $109.6M |
| **Total Liabilities** | $93.97M | $126.0M | $403.5M | $338.0M | $223.4M | $168.2M | $180.8M | $168.5M | $128.8M | $140.0M |
| **Total Debt (incl. Leases)** | $82.97M | $91.64M | $207.2M | $161.5M | $48.62M | $40.68M | $45.13M | -- | -- | -- |
| Common Stock | $10K | $9.0K | $135K | $125K | $92K | $91K | $70K | $41K | $40K | $40K |
| Retained Earnings | -$972.4M | -$978.1M | -$978.2M | -$864.5M | -$614.4M | -$548.8M | -$459.6M | -$389.4M | -$263.6M | -$174.2M |
| Accumulated Other Comp. Income | -- | $0 | $0 | -$12K | -$60K | -$47K | -- | -- | -$146K | -$149K |
| **Total Stockholders' Equity** | $44.22M | $13.78M | -$44.86M | $10.78M | $131.5M | $174.8M | -$48.32M | -$48.05M | $60.70M | $132.6M |
| Total Equity | $44.22M | $13.78M | -$44.86M | $10.78M | $131.5M | $174.8M | -$48.32M | -$48.05M | $60.70M | $132.6M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $17.53M | $15.59M | $29.83M | $45.77M | $47.64M | $45.38M | $58.85M | $30.79M |
| **Cash & Short-Term Investments** | $17.53M | $15.59M | $29.83M | $45.77M | $47.64M | $45.38M | $58.85M | $30.79M |
| Accounts Receivable, Net | $183K | $274K | $233K | $157K | $351K | -- | -- | $0 |
| **Total Current Assets** | $34.42M | $42.35M | $31.84M | $49.38M | $51.53M | $48.69M | $66.08M | $38.67M |
| Property, Plant & Equipment, Net | $3.00M | $5.80M | $6.85M | $7.63M | $8.58M | $9.62M | $10.55M | $11.53M |
| Other Non-Current Assets | $31K | $31K | $31K | $31K | $31K | $31K | $31K | $31K |
| **Total Non-Current Assets** | $31.46M | $59.24M | $85.78M | $88.82M | $91.95M | $95.11M | $98.10M | $101.1M |
| **Total Assets** | $65.89M | $101.6M | $117.6M | $138.2M | $143.5M | $143.8M | $164.2M | $139.8M |
| Accounts Payable | $1.46M | $1.19M | $2.34M | $1.68M | $1.68M | $2.20M | $2.17M | $4.08M |
| **Total Current Liabilities** | $20.89M | $20.03M | $19.34M | $19.32M | $22.43M | $30.94M | $31.32M | $41.22M |
| Other Non-Current Liabilities | $514K | $2.21M | $2.14M | $2.08M | $2.01M | $1.95M | $1.90M | $1.84M |
| **Total Non-Current Liabilities** | $23.64M | $47.02M | $71.78M | $74.65M | $77.35M | $79.91M | $82.39M | $84.80M |
| **Total Liabilities** | $44.53M | $67.05M | $91.12M | $93.97M | $99.78M | $110.8M | $113.7M | $126.0M |
| **Total Debt (incl. Leases)** | $35.77M | $56.64M | $80.50M | $82.97M | $85.25M | $87.43M | $89.55M | $91.64M |
| Common Stock | $10K | $10K | $10K | $10K | $9.0K | $9.0K | $9.0K | $9.0K |
| Retained Earnings | -$1.00B | -$987.7M | -$992.3M | -$972.4M | -$957.1M | -$965.3M | -$945.4M | -$978.1M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $0 | $0 | -- | $0 |
| **Total Stockholders' Equity** | $21.36M | $34.53M | $26.50M | $44.22M | $43.70M | $32.95M | $50.47M | $13.78M |
| Total Equity | $21.36M | $34.53M | $26.50M | $44.22M | $43.70M | $32.95M | $50.47M | $13.78M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $5.70M | $136K | -$113.7M | -$250.2M | -$65.58M | -$89.13M | -$70.28M | -$98.94M | -$89.38M | -$91.58M |
| Depreciation & Amortization | $4.13M | $5.47M | $6.24M | $6.63M | $5.95M | $6.58M | $7.60M | $7.86M | $7.26M | $4.21M |
| Stock-Based Compensation | $10.84M | $20.97M | $34.10M | $25.48M | $20.22M | $8.82M | $8.34M | $16.64M | $17.36M | $16.86M |
| Change in Receivables | -$157K | $0 | $0 | $0 | $9.39M | -$7.60M | -$1.78M | -- | -- | -- |
| Change in Inventory | $0 | -$33.80M | -$29.65M | $0 | $0 | -- | -- | -- | -- | -- |
| Change in Payables | -$2.40M | -$2.94M | -$11.58M | $2.20M | $9.36M | -$1.16M | -$1.46M | -$353K | -$856K | $3.58M |
| **Operating Cash Flow** | $1.12M | -$148.6M | -$117.4M | -$228.8M | $6.69M | -$93.61M | -$76.52M | -$62.85M | -$75.52M | $43.92M |
| Capital Expenditure | -$252K | -$380K | -$7.97M | -$9.82M | -$9.57M | -$591K | -$1.00M | -$1.94M | -$4.68M | -$21.49M |
| **Free Cash Flow** | $865K | -$149.0M | -$125.3M | -$238.6M | -$2.88M | -$94.20M | -$77.52M | -$64.79M | -$80.20M | $22.43M |
| Purchases of Investments | $0 | $0 | -$4.43M | -$48.22M | -$95.97M | -$218.3M | -$46.42M | -$21.83M | -$97.93M | -$290.6M |
| Sales & Maturities of Investments | $0 | $0 | $22.98M | $140.5M | $169.6M | $59.98M | $16.90M | $136.1M | $158.3M | $246.5M |
| **Investing Cash Flow** | -$42K | $142.3M | $10.58M | $82.43M | $64.09M | -$158.9M | -$30.52M | $112.3M | $55.70M | -$65.59M |
| Common Stock Issued | -- | $0 | $0 | $96.72M | $0 | $243.7M | $60.53M | -- | -- | -- |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -- | -- | -$33K | -- |
| **Financing Cash Flow** | $13.90M | -$90.37M | $71.70M | $129.6M | $1.18M | $303.4M | $86.23M | $268K | $83K | $2.14M |
| **Net Change in Cash** | $14.97M | -$96.69M | -$35.07M | -$16.79M | $71.95M | $50.92M | -$20.81M | $49.73M | -$19.74M | -$19.53M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$16.29M | $4.58M | -$19.91M | -$15.34M | $8.20M | -$19.86M | $32.68M | -$15.64M |
| Depreciation & Amortization | $481K | $670K | $781K | $954K | $1.04M | $1.06M | $1.08M | $1.08M |
| Stock-Based Compensation | $1.86M | $1.74M | $1.77M | $3.20M | $2.48M | $2.34M | $2.82M | $3.77M |
| Change in Receivables | $91K | -$41K | -$76K | $194K | -$351K | $0 | $0 | -- |
| Change in Inventory | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| Change in Payables | $275K | -$1.15M | $656K | $5.0K | -$515K | $79K | -$1.97M | -$4.16M |
| **Operating Cash Flow** | -$10.48M | -$22.39M | -$16.36M | -$14.71M | $2.21M | -$13.29M | $26.91M | -$38.88M |
| Capital Expenditure | $0 | $0 | $0 | -$29K | -$8.0K | -$181K | -$34K | -$90K |
| **Free Cash Flow** | -$10.48M | -$22.39M | -$16.36M | -$14.74M | $2.20M | -$13.47M | $26.88M | -$38.97M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| Sales & Maturities of Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Investing Cash Flow** | $12.55M | $14K | $0 | $181K | -$8.0K | -$181K | -$34K | -$90K |
| **Financing Cash Flow** | $752K | $1.72M | $428K | $12.66M | $61K | $0 | $1.18M | $1.74M |
| **Net Change in Cash** | $2.83M | -$20.66M | -$15.93M | -$1.87M | $2.26M | -$13.47M | $28.06M | -$37.23M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -11910.1% | -- | -- | -2524.0% | -44.5% | -265.3% | -208.3% | -354.8% | -284.7% | -426.5% |
| **Net Profit Margin** | 721.9% | -- | -- | -3509.5% | -45.2% | -268.3% | -203.7% | -350.0% | -278.4% | -420.7% |
| Return on Equity (ROE) | 12.9% | 1.0% | -- | -2319.9% | -49.9% | -51.0% | -- | -- | -147.3% | -69.0% |
| Return on Assets (ROA) | 4.1% | 0.1% | -31.7% | -71.7% | -18.5% | -26.0% | -53.1% | -82.1% | -47.2% | -33.6% |
| Current Ratio | 2.56x | 0.94x | 1.78x | 2.28x | 3.69x | 5.79x | 2.18x | 2.20x | 4.90x | 6.51x |
| Quick Ratio | 2.38x | 0.75x | 1.48x | 2.28x | 3.53x | 5.67x | 2.10x | 2.04x | 4.74x | 7.55x |
| Debt to Equity | 1.88x | 6.65x | -- | 14.98x | 0.37x | 0.23x | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -100.0% | -95.1% | +336.3% | -3.7% | +22.1% | -11.9% | +47.5% | -- |
| **Net Income Growth (YoY)** | +4088.2% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -3521.3% | -- | -- | -- | -- | -272.0% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -457.6% | -- |
| 5Y Revenue / Share Growth | -78.6% | -100.0% | -100.0% | -91.7% | +189.3% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -3656.9% | -4462.8% | -7641.0% | -11910.1% | -29467.0% | -- | -- | -- |
| **Net Profit Margin** | -2209.6% | -1192.9% | -4088.8% | 721.9% | 1536.8% | -- | -- | -- |
| Return on Equity (ROE) | -219.8% | -65.0% | -177.0% | 12.9% | 12.3% | 260.9% | 144.6% | 1.0% |
| Return on Assets (ROA) | -71.3% | -22.1% | -39.9% | 4.1% | 3.8% | 59.8% | 44.4% | 0.1% |
| Current Ratio | 1.65x | 2.11x | 1.65x | 2.56x | 2.30x | 1.57x | 2.11x | 0.94x |
| Quick Ratio | 0.85x | 0.79x | 1.55x | 2.38x | 2.14x | 1.47x | 1.88x | 0.75x |
| Debt to Equity | 1.67x | 1.64x | 3.04x | 1.88x | 1.95x | 2.65x | 1.77x | 6.65x |
| **Revenue Growth (YoY)** | +68.9% | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -298.5% | -- | -160.9% | -- | -90.8% | -- | -- | -- |
| EPS Growth (YoY) | -273.4% | -- | -155.3% | -- | -91.9% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -574.9% | -- | -160.8% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -576.7% | -- | -160.9% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
